Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

CDER Pharmaceutical Quality Office Gains Permanent Director

This article was originally published in The Pink Sheet Daily

Executive Summary

Former Novartis exec to join FDA in November.


Related Content

CDER’s 50 Open Leadership Posts Could Be Bigger Hiring Challenges After Trump Freeze
FDA Drug Policy Office Reshuffled Over ‘Spousal Employment’ Conflict
CBER Director Midthun Retiring; Legacy Includes Biosimilar Principles, Avastin Withdrawal
FDA Generics Director’s Departure Shows Why Chemistry Matters
FDA Resurrects Park Doctrine in Enforcement of Pharmaceutical GMPs


Related Companies